🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Intraindividual Comparison of EMO IOLs

RecruitingNAAges 50 Years - 100 YearsAllMedical University of Vienna
NCT05822089 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be implemented in accordance with the approved investigational plan.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Bilateral age-related cataract planned for phacoemulsification extraction and posterior IOL implantation * Age 50 to 100 * Visual potential in both eyes of 20/25 or better as determined by investigators estimation * Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant * Irregular Astigmatism (Acrysof IQ Vivity IOL, IC-8 Apthera IOL) * postoperativ binocular best corrected distance visual acuity (BCVA) ≥ 1.0 decimal (Arm ten (X)) * Standard cataract surgery with bilateral implantation of a monofocal IOL (Vivinex XC1 or Vivinex XY1) (Arm ten (X)) Exclusion Criteria: * Preceding intraocular surgery or ocular trauma * Relevant other ophthalmic diseases that particularly effects the zonular apparatus (such as severe pseudoexfoliation syndrome, preceding cryocoagulation, trauma) * Pupil diameter \< 2.0 mm (photopic) * Laser treatment * Uncontrolled systemic or ocular disease * Pregnancy/Nursing * childbearing ability
💊

What it tests

  • phacoemulsification and intraocular lens implantation
  • phacoemulsification and intraocular lens implantation
  • phacoemulsification and intraocular lens implantation
  • phacoemulsification and intraocular lens implantation
  • phacoemulsification and intraocular lens implantation
📍

Where

1 site
Medical University of Vienna
Vienna, Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy